These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24867793)

  • 21. Vasoactive intestinal peptide attenuates concanavalin A-mediated liver injury.
    Luo Q; Wang Y; Feng D; Xu Y; Xu L
    Eur J Pharmacol; 2009 Apr; 607(1-3):226-33. PubMed ID: 19222997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The protective action of scutellarin against immunological liver injury induced by concanavalin A and its effect on pro-inflammatory cytokines in mice.
    Tan ZH; Yu LH; Wei HL; Liu GT
    J Pharm Pharmacol; 2007 Jan; 59(1):115-21. PubMed ID: 17227628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapamycin prevents concanavalin A-induced liver injury by inhibiting lymphocyte activation.
    Zhang Y; Xiao X; Li X; Wei H
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1457-62. PubMed ID: 19496899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zingerone attenuates concanavalin A-induced acute liver injury by restricting inflammatory responses.
    Liu Z; Yan F; Zhang H; Wang L; Zhao Y; Zhao H; Li C; Dai J; Yu B; Xiong H; Zhang J
    Int Immunopharmacol; 2024 Dec; 142(Pt B):113198. PubMed ID: 39305891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-Methylnicotinamide protects against liver injury induced by concanavalin A via a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α.
    Jakubowski A; Sternak M; Jablonski K; Ciszek-Lenda M; Marcinkiewicz J; Chlopicki S
    Int Immunopharmacol; 2016 Feb; 31():98-104. PubMed ID: 26709075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toll-like receptor 5 signaling restrains T-cell/natural killer T-cell activation and protects against concanavalin A-induced hepatic injury.
    Wang L; Zhang W; Ge CH; Yin RH; Xiao Y; Zhan YQ; Yu M; Li CY; Ge ZQ; Yang XM
    Hepatology; 2017 Jun; 65(6):2059-2073. PubMed ID: 28273362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hesperidin Alleviates Hepatic Injury Caused by Deoxynivalenol Exposure through Activation of mTOR and AKT/GSK3β/TFEB Pathways.
    Wang X; Chen H; Jiang J; Ma J
    J Agric Food Chem; 2024 Jun; 72(25):14349-14363. PubMed ID: 38869217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of andrographolide against concanavalin A-induced liver injury.
    Shi G; Zhang Z; Zhang R; Zhang X; Lu Y; Yang J; Zhang D; Zhang Z; Li X; Ning G
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Jan; 385(1):69-79. PubMed ID: 21947229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretreatment with dihydroquercetin, a dietary flavonoid, protected against concanavalin A-induced immunological hepatic injury in mice and TNF-α/ActD-induced apoptosis in HepG2 cells.
    Chen J; Sun X; Xia T; Mao Q; Zhong L
    Food Funct; 2018 Apr; 9(4):2341-2352. PubMed ID: 29589006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Serotonin in Concanavalin A-Induced Liver Injury in Mice.
    Pang Q; Jin H; Ke X; Man Z; Wang Y; Tan Y; Lu Z; Liu H
    Oxid Med Cell Longev; 2020; 2020():7504521. PubMed ID: 31998441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paeoniflorin protects against concanavalin A-induced hepatitis in mice.
    Chen M; Cao L; Luo Y; Feng X; Sun L; Wen M; Peng S
    Int Immunopharmacol; 2015 Jan; 24(1):42-9. PubMed ID: 25479726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beneficial effect of hesperidin on lipopolysaccharide-induced hepatotoxicity.
    Kaur G; Tirkey N; Chopra K
    Toxicology; 2006 Sep; 226(2-3):152-60. PubMed ID: 16919860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice.
    Toyabe S; Seki S; Iiai T; Takeda K; Shirai K; Watanabe H; Hiraide H; Uchiyama M; Abo T
    J Immunol; 1997 Aug; 159(3):1537-42. PubMed ID: 9233653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) reduces hepatic injury in concanavalin A-treated mice.
    Ko YE; Yoon SY; Ly SY; Kim JH; Sohn KY; Kim JW
    J Cell Biochem; 2018 Feb; 119(2):1392-1405. PubMed ID: 28749086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin attenuated acute Propionibacterium acnes-induced liver injury through inhibition of HMGB1 expression in mice.
    Gu Q; Guan H; Shi Q; Zhang Y; Yang H
    Int Immunopharmacol; 2015 Feb; 24(2):159-165. PubMed ID: 25510585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice.
    Santucci L; Fiorucci S; Cammilleri F; Servillo G; Federici B; Morelli A
    Hepatology; 2000 Feb; 31(2):399-406. PubMed ID: 10655263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin C exerts beneficial hepatoprotection against Concanavalin A-induced immunological hepatic injury in mice through inhibition of NF-κB signal pathway.
    Liang T; Chen X; Su M; Chen H; Lu G; Liang K
    Food Funct; 2014 Sep; 5(9):2175-82. PubMed ID: 25030772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A humanized anti-osteopontin antibody protects from Concanavalin A induced-liver injury in mice.
    Fan K; Zhang B; Yang H; Wang H; Tan M; Hou S; Qian W; Li B; Wang H; Dai J; Guo Y
    Eur J Pharmacol; 2011 Apr; 657(1-3):144-51. PubMed ID: 21300057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.
    Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
    Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice.
    Kato J; Okamoto T; Motoyama H; Uchiyama R; Kirchhofer D; Van Rooijen N; Enomoto H; Nishiguchi S; Kawada N; Fujimoto J; Tsutsui H
    Hepatology; 2013 Jan; 57(1):362-72. PubMed ID: 22936459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.